Current Report Filing (8-k)
October 02 2017 - 10:39AM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE
COMMISSION
WASHINGTON, DC 20549
FORM 8-K
CURRENT
REPORT Pursuant to
Section 13 or 15(d) of the Securities
Exchange Act of 1934
Date of report (Date
of earliest event reported): October 2, 2017
STAAR Surgical Company
(Exact Name of Registrant
as Specified in Charter)
Delaware
|
|
0-11634
|
|
95-3797439
|
(State or Other Jurisdiction
of Incorporation)
|
|
(Commission
File Number)
|
|
(I.R.S. Employer
Identification No.)
|
1911 Walker
Ave., Monrovia, California
|
|
91016
|
(Address of Principal Executive Offices)
|
|
(Zip Code)
|
|
|
|
Registrant’s
Telephone Number, Including Area Code
626-303-7902
|
|
|
|
|
|
Not Applicable
|
|
|
(Former Name or Former Address, if Changed Since
Last Report)
Check the appropriate box below if the Form 8-K
filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (
see
General Instruction A.2. below):
|
¨
|
Written
communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
|
¨
|
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
|
¨
|
Pre-commencement
communication pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
|
¨
|
Pre-commencement
communication pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Indicate by check mark whether the registrant is
an emerging growth company as defined in Rule 405 of the Securities Act of 1 933 (17 CFR §230.405) or Rule 12b-2 of the Securities
Exchange Act of 1934 (17 CFR §240.12b-2).
Emerging growth company
¨
If an emerging growth company, indicate by check
mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting
standards provided pursuant to Section 13(a) of the Exchange Act.
¨
Item 7.01 Regulation FD Disclosure.
STAAR Surgical Company issued a press release
regarding the appointment of Dr. Scott Barnes as Chief Medical Officer. A copy of the press release is furnished as Exhibit 99.1
to this Report, and is incorporated herein by this reference.
The
information furnished herewith pursuant to Item 7.01 of this Current Report, including Exhibit 99.1, shall not be deemed to be
“filed” for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”),
or otherwise subject to the liabilities of that section. The information in Item 7.01 of this Current Report shall not be incorporated
by reference into any filing under the Securities Act of 1933, as amended, or the Exchange Act, whether made before or after the
date of this Current Report, regardless of any general incorporation language in the filing
.
Item 9.01
Financial Statements and Exhibits
SIGNATURE
Pursuant to the requirements of the Securities Exchange
Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
STAAR Surgical Company
|
|
October 2, 2017
|
By:
|
/s/ Caren Mason
|
|
|
Caren Mason
|
|
|
President and Chief Executive Officer
|
STAAR Surgical (NASDAQ:STAA)
Historical Stock Chart
From Jun 2024 to Jul 2024
STAAR Surgical (NASDAQ:STAA)
Historical Stock Chart
From Jul 2023 to Jul 2024